Pages with the most revisions
From OncoWiki
Jump to navigationJump to search
Showing below up to 50 results in range #1 to #50.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- EPOCH-DA (16 revisions)
- Adrenocortical Carcinoma (11 revisions)
- Main Page (11 revisions)
- Acute Myeloid Leukemia,Adult (10 revisions)
- Stem Cell Transplantation (8 revisions)
- Lymphoma Non-Hodgkin's, Adult (6 revisions)
- Multiple Myeloma And Plasma Cell Dyscrasias (6 revisions)
- Lymphoma Hodgkin's, Adult (5 revisions)
- Cyclophosphamide Bortezomib Dexamethasone (4 revisions)
- Cytotoxic Regimens (4 revisions)
- CLAG-M (4 revisions)
- BEAM (4 revisions)
- SMILE (3 revisions)
- Brentuximab vedotin (3 revisions)
- ATRA plus As203 (3 revisions)
- Clofarabine, cyclophosphamide and etoposide (3 revisions)
- Cancer treatment information (3 revisions)
- Guidelines for contributors (3 revisions)
- FOLFIRINOX (3 revisions)
- Pancreatic Cancer (3 revisions)
- APL4 - ALLG (3 revisions)
- Pentostatin (2 revisions)
- Arsenic Trioxide for relapsed APML (2 revisions)
- Rituximab (2 revisions)
- Brain Tumors Adult (2 revisions)
- Temozolomide (2 revisions)
- CMF (2 revisions)
- VIP (2 revisions)
- Carboplatin + Irinotecan (2 revisions)
- Cisplatin (2 revisions)
- Cisplatin + Pemetrexed (2 revisions)
- Dacarbazine (2 revisions)
- ECF (2 revisions)
- FCM (2 revisions)
- FP + Surgery +/- FP (2 revisions)
- Gemcitabine + Cisplatin + Paclitaxel (2 revisions)
- HyperCVAD (2 revisions)
- LV + 5-FU + Irinotecan + Bevacizumab (2 revisions)
- MOPPABV Hybrid (2 revisions)
- 5-FU + Cisplatin + RT (2 revisions)
- Oblimersen + Dacarbazine (2 revisions)
- ADE (2 revisions)
- Plerixafor and G-CSF (2 revisions)
- Azacitidine (2 revisions)
- Rituximab, Bendamustine, Bortezomib (2 revisions)
- Breast Cancer (2 revisions)
- Temozolomide + IFN (2 revisions)
- CMV (2 revisions)
- VMPT (2 revisions)
- Carboplatin + Paclitaxel (2 revisions)